Plasma triglyceride (TG) concentration is reemerging as an important cardiovascular
disease risk factor. More complete understanding of the genes and variants that modulate
plasma TG should enable development of markers for risk prediction, diagnosis, prognosis,
and response to therapies and might help specify new directions for therapeutic
interventions. Recent genome-wide association studies (GWAS) have identified both known
and novel loci associated with plasma TG concentration. However, genetic variation at these …